PsA: T-Cell Blockade
Orencia Approved for Use in Psoriatic Arthritis On July 6 the U.S. Food and Drug Administration (FDA) approved ORENCIA (abatacept) for the treatment of adults with active Psoriatic Arthritis (PsA).……
The 9 Muses are daughters of Zeus and Mnemosyne, Greek goddesses personifying the inspiration for the sciences and the arts.
My highly opinionated news-blog draws inspiration from both the science and the art of Rheumatology.
PsA: JAK Inhibition
Tofacitinib Scores in TNF inhibitor Resistant Psoriatic Arthritis Mease et al has reported in the NEJM the results of a phase 3 trial showing tofacitinib (Tofa) to be significantly more effective…
PsA: IL23 Inhibition
Targeting IL-23 a Hit in Psoriatic Arthritis Multiple disease domains showed significant improvement medpagetoday.com Guselkumab Improves Psoriatic Arthritis in Phase 2a Study Guselkumab significantly improved joint symptoms, physical function, psoriasis,…
PsA: IL17 Inhibition
IL-17 Inhibition in Spondyloarthritis: A Targeted Approach in Psoriatic Arthritis Prof Philip Mease introduced psoriatic arthritis (PsA) with a particular emphasis on disease symptoms and an update on the status…
PsA: Triggers & Flares
Psoriatic arthritis flare-ups: Triggers, symptoms, and treatment In this article, we take a close look at a variety of triggers for psoriatic arthritis flare-ups, as well as what can be…
New PsA Guideline: Anti-TNF is Firstline
New management guidelines for PsA use GRADE methodology The ACR is about to release its first-ever guideline for the management of psoriatic arthritis (PsA). Written in conjunction with the National…
PsA: Treat-to-Target
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force Therapeutic targets have been defined for axial and peripheral spondyloarthritis…
Predicting Bad PsA
Identifying Preclinical Psoriatic Arthritis in Hope of Prevention Dr Kevin Deane explains how this new research may provide a window of opportunity for preventing psoriatic arthritis. medscape.com "A variety of…
Risks of PsA
The effects of structural damage on functional disability in psoriatic arthritis Background Functional outcomes are central in patients with chronic inflammatory… ard.bmj.com Damage, especially joint space narrowing, predicts for eventual…
Psoriatic Arthritis (PsA)
New England Journal of Medicine Reviews Psoriatic Arthritis A comprehensive review of psoriatic arthritis (PsA) was published this week in the NEJM, authored by leaders in the field, Drs. Ritchlin,…
- Go to the previous page
- 1
- …
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- …
- 108
- Go to the next page